Recurrence of Bladder Cancer After Transurethral Resection With Hexvix.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 Mar 2015
At a glance
- Drugs Hexyl aminolevulinate (Primary) ; Mitomycin
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors GE Healthcare
- 10 Feb 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 22 Nov 2008 New trial record.